Markets:

Overview

News

Currencies

International

Treasuries

Gracell Biotechnologies Inc. - American Depositary Shares (NQ:GRCL)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Feb 21, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Gracell Biotechnologies Inc. - American Depositary Shares

< Previous 1 2 3 4 5 Next >

Week In Review: Shanghai Inmagene Signs $230 Million Deal To Develop Two HutchMed Immunology Assets ↗

February 03, 2024

Inmagene Biopharma of Shanghai transferred 7.5% of its shares to HutchMed for global rights to two clinical stage immunology assets. It will also be responsible for up to $230 million in milestones.

Via Talk Markets

Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment ↗

January 23, 2024

In a significant development, the FDA is set to impose a classwide black box warning following its investigation into secondary T-cell cancers arising from the use of existing CAR-T therapies.

Via Benzinga

With its sale to AstraZeneca, Gracell blazes exit trail for cash-challenged Chinese biotechs ↗

January 05, 2024

Key Takeaways: AstraZeneca will acquire Chinese cell therapy maker Gracell for up to $1.2 billion, representing an 86% premium to the company’s pre-announcement share price

Via Benzinga

Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024 ↗

January 05, 2024

Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain.

Via Investor's Business Daily

Health Care Company AstraZeneca Announces Acquisition of Gracell Biotechnologies ↗

December 26, 2023

Via Benzinga

A Preview Of Gracell Biotechnologies's Earnings ↗

November 10, 2023

Via Benzinga

Week In Review: $1.7 Billion Collaboration Between Elpiscience And Astellas Is Final 2023 Deal ↗

December 31, 2023

Shanghai’s Elpiscience Biopharma has formed a $1.7 billion collaboration with Japan’s Astellas Pharma to develop a novel bispecific macrophage engager, ES019, along with an unspecified program....

Via Talk Markets

Stock Market Ending 2023 On High Note; Tesla, Drug M&A In Focus: Weekly Review ↗

December 29, 2023

The major indexes boast big annual gains with the Dow at record highs.

Via Investor's Business Daily

Topics Stocks

Investor Sentiment Improves; Dow Jumps Over 150 Points ↗

December 27, 2023

The CNN Money Fear and Greed index showed an increase in overall market sentiment, while the index remained in the "Extreme Greed" zone on Tuesday.

Via Benzinga

Topics Stocks

Nasdaq Surges 75 Points; Inspira Technologies Shares Spike Higher ↗

December 26, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 150 points on Tuesday. The Dow traded up 0.50% to 37,574.66 while the NASDAQ rose 0.50% to 15,068.50. The...

Via Benzinga

Topics Stocks

The Latest Analyst Ratings for Gracell Biotechnologies ↗

October 19, 2023

Via Benzinga

4 Analysts Have This to Say About Gracell Biotechnologies ↗

August 30, 2023

Via Benzinga

Preview: Gracell Biotechnologies's Earnings ↗

August 11, 2023

Via Benzinga

Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

December 26, 2023

Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

December 26, 2023

Via Benzinga

Crude Oil Rises Over 3%; US Home Prices Increase In October ↗

December 26, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 100 points on Tuesday. The Dow traded up 0.34% to 37,511.87 while the NASDAQ rose 0.43% to 15,057.13. The...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 26, 2023

Via Benzinga

Why Sentage Holdings Shares Are Trading Lower By 5%; Here Are 20 Stocks Moving Premarket ↗

December 26, 2023

Shares of Sentage Holdings Inc. (NASDAQ: SNTG) shares moved lower in pre-market trading following results for the six months ended June 30, 2023.

Via Benzinga

US Stocks Set To Start Final Trading Week Of Year On Positive Note As Santa Claus Rally Gets Going: Analyst Confident Of Market Finishing Year At Highs ↗

December 26, 2023

Stocks appear on track to start Tuesday's session on a positive note amid positive expectations concerning interest rates and economy.

Via Benzinga

AstraZeneca Bolsters Cell Therapy Pipeline With Over $1B Deal For China-Based Gracell Biotechnologies ↗

December 26, 2023

AstraZeneca Plc (NASDAQ: AZN) has agreed to acquire Gracell Biotechnologies Inc (NASDAQ: GRCL), further strengthening AstraZeneca's cell therapy portfolio.

Via Benzinga

Gracell Biotechnologies, Stratasys, Hollysys Automation Technologies And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session ↗

December 26, 2023

U.S. stock futures were higher this morning, with the Dow Jones futures gaining more than 40 points on Tuesday.

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

December 12, 2023

Via Benzinga

Week In Review: Tang Capital Offers $465 Million For LianBio Plus 80% Of Any Licenses/Divestments ↗

December 02, 2023

LianBio received a $465 million buyout offer from Tang Capital Management. In addition, Tang also offered shareholders a contingent value right for 80% of net proceeds from any license or divestment of...

Via Talk Markets

Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

November 28, 2023

Shares of SenesTech, Inc. (NASDAQ: SNES) shares moved lower during Tuesday’s session after the company reported pricing of $5.0 million public offering.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 28, 2023

Via Benzinga

Bitfarms And Other Big Stocks Moving Lower On Friday ↗

November 24, 2023

U.S. stocks traded mixed, with the Dow Jones gaining around 90 points on Friday. Shares of Bitfarms Ltd. (NASDAQ: BITF) shares fell sharply during Friday’s session after the company announced a C$60...

Via Benzinga

Topics Stocks

Earnings Scheduled For November 13, 2023 ↗

November 13, 2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2023 ↗

October 19, 2023

Via Benzinga

Week In Review: Adlai Nortye Stages $97.5 Million US IPO On Nasdaq ↗

September 30, 2023

While ANL's IPO dropped more than 25% on its first day, netting just under $60M, private placement made up the difference. Plus: Deals, financings, trials and approvals.

Via Talk Markets

Topics Initial Public Offering

Week In Review: BeiGene And Bristol-Myers Squibb Close BeiGene-Celgene PD-1 Partnership ↗

August 12, 2023

BeiGene and Bristol-Myers Squibb have formally completed the breakup of the BeiGene-Celgene partnership, returning 23.3 million ordinary BeiGene shares to BeiGene. Meanwhile, Gracell Biotechnologies...

Via Talk Markets

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.